Ultrasonic Vocalizations as a Measure of Affect in Preclinical Models of Drug Abuse: A Review of Current Findings

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|13|2|193-210

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.13, Iss.2, 2015-03, pp. : 193-210

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Review of Preclinical Research Demonstrating that Drug and Non-Drug ReinforcersDifferentially Affect Behavior

By  

Current Drug Abuse Reviews, Vol. 4, Iss. 4, 2011-12 ,pp. : 261-269

Bentham Science Publishers

Access to resources Recommend Favorite

A Review of: "Preclinical Drug Development"

By Keep Marcus F.  

Drug Development and Industrial Pharmacy, Vol. 33, Iss. 4, 2007-04 ,pp. : 493-493

Informa Healthcare

Access to resources Recommend Favorite

Preclinical models for pediatric solid tumor drug discovery: current trends, challenges and the scopes for improvement

By Kumar Sushil   Mokhtari Reza Bayat   Yeger Herman   Baruchel Sylvain  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 11, 2012-11 ,pp. : 1093-1106

Informa Healthcare

Access to resources Recommend Favorite

In Vivo Models of Childhood Leukemia for Preclinical Drug Testing

By  

Current Drug Targets, Vol. 8, Iss. 6, 2007-06 ,pp. : 773-783

Bentham Science Publishers

Access to resources Recommend Favorite

Species differences in drug transporters and implications for translating preclinical findings to humans

By Chu Xiaoyan   Bleasby Kelly   Evers Raymond  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 3, 2013-03 ,pp. : 237-252

Informa Healthcare

Access to resources Recommend Favorite